Section Arrow
NRXS.NYSE-M
- Neuraxis
Quotes are at least 15-min delayed:2025/07/13 07:37 EDT
Regular Hours
Last
 2.4
-0.01 (-0.41%)
Day High 
2.59 
Prev. Close
2.41 
1-M High
2.7499 
Volume 
98.92K 
Bid
2.36
Ask
2.51
Day Low
2.4 
Open
2.46 
1-M Low
2.23 
Market Cap 
22.96M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.48 
20-SMA 2.47 
50-SMA 2.52 
52-W High 6.2 
52-W Low 1.33 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-1.23/--
Enterprise Value
23.22M
Balance Sheet
Book Value Per Share
0.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.69M
Operating Revenue Per Share
0.28
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0502-0.0095-15.91%-- 
INKTMiNK Therapeutics Inc64.17+56.44+730.14%-- 
RXRXRecursion Pharmaceuticals5.28-0.435-7.61%-- 
CVMCel-Sci Corp3.53-0.29-7.59%-- 
MISTMilestone Pharmaceuticals1.56-1-39.06%-- 
Quotes are at least 15-min delayed:2025/07/13 07:37 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.